Previous studies of the ALT/AST ratio have focused on the correlation between the ALT/AST ratio and cardiometabolic disease risk, muscle mass in patients with T2DM, and gastrointestinal tumors (21, 34, 35). The gene discussed is GPT; the disease is digestive system neoplasm.